Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
This disease is selected. Its supporting articles are shown below.
…igen that may be suitable for CAR T-cell targeting in pediatric solid tumors, including those of the CNS.…
…reclinical-to-clinical translation of CAR-T therapies targeting solid tumors is still a challenging task because of their unique “live cell”…
…mprove adoptive T-cell therapies, particularly CAR-T cells, for solid tumors.…
…rategy for overcoming the limitations of CAR T cell therapy for solid tumors. This approach enhances immune cell infiltration and activation…
…p_GAIA+rhIL-2 as a new NK-based strategy for durable control of solid tumors.…
…cal malignancies, its application in solid tumors, particularly GIM, remains in its nascent stages. This comprehensive landscape an…
…ssues, LAR CAR-T overcomes key barriers of efficacy and OTOT in solid tumors. This lactic acid-sensing paradigm offers a clinically translat…
…omal barriers and enhance the efficacy of CAR-T cell therapy in solid tumors.…
…romising clinical progress in both hematologic malignancies and solid tumors; however, their therapeutic efficacy is still limited by multip…
…ports the development of an antitumor immune memory response in solid tumors. This study supports clinical development of this combination s…
…natures, using DNA and RNA profiling to predict outcomes across solid tumors receiving ICIs. While this assay is promising, further prospect…
…e of surface proteins amenable to CAR-T cell-based therapies in solid tumors.…